Top Pharma companies not following current good manufacturing processes: Angiotensin II receptor blockers with carcinogenic impurities: A threat to global public health
Author(s) -
Aslam Pathan
Publication year - 2019
Publication title -
neuropharmac journal
Language(s) - English
Resource type - Journals
ISSN - 2456-3927
DOI - 10.37881/1.432
Subject(s) - business , angiotensin ii , carcinogen , impurity , current (fluid) , public health , receptor , pharmacology , medicine , chemistry , biochemistry , engineering , nursing , organic chemistry , electrical engineering
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom